Caricamento...
Gene therapy in an era of emerging treatment options for hemophilia B
Factor IX deficiency (hemophilia B) is less common than factor VIII deficiency (hemophilia A) and innovations in therapy for hemophilia B have generally lagged behind those for hemophilia A. Recently the first sustained correction of the hemophilia bleeding phenotype by clotting factor gene therapy...
Salvato in:
| Pubblicato in: | J Thromb Haemost |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4712690/ https://ncbi.nlm.nih.gov/pubmed/26149016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.12957 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|